PROTEST: FDA Dashboard and Analytics BPA
Posted (Last updated )
**Updated May 4, 2017
** Updated April 3, 2017
G2X TAKE: It appears that a 5-year $28M BPA focused on the development, implementation, and maintenance of a series of external and internal facing dashboards that was already challenged once and dismissed by GAO has not yet been put to rest.
This past week, REI Systems once again levied a protest on this contract awarded to Triple I (now part of Salient CRGT) in support of the FDA’s expanded adoption of a dashboard solution to promote transparency and accountability. REI had previously protested this award this past Fall, with GAO marking the protest as dismissed, at least in their eyes, last November. Dismissed does not always mean the protest is resolved, as it can many times indicate that the agency has agreed to take some type of corrective action to remedy issues identified by the protesting party. No additional information has been released at this time by GAO as to the rationale for this latest challenge, nor any of the actions taken by FDA at this point. The due date for a potential resolution is listed as July 7, 2017.
Posted December 7, 2017
Update: This protest has been marked as dismissed. No additional details provided
**Posted November 7, 2016
G2X TAKE: The award of this 5 year $28M BPA focused on the development, implementation, and maintenance of a series of external and internal facing dashboards for FDA has been protested. Details as to grounds for the challenge put forth by protestor REI Systems has yet to be released. The challenge is expected to be resolved by late February 2017.
Awarded to Triple I, this contract is to support the FDA’s expanded adoption of a dashboard solution to promote transparency and accountability, while helping leadership to improve the Agency's data quality and allow users to easily spot trends and exceptions that represent potential public health risks
Have something you would like to add? Comment below
Note: You will need to be logged in as a member to see comments and participate in the discussion.